三七皂苷R2经CASP2/ALDH3A1轴调控脂肪酸氧化拮抗肾间质纤维化
本研究在单侧输尿管梗阻(UUO)大鼠与TGF-β1诱导的NRK-52E细胞中,采用多组学分析鉴定肾炎防衰方核心活性成分三七皂苷R2(NGR2)直接结合caspase-2(CASP2)。NGR2上调CASP2、增强CASP2与ALDH3A1相互作用并促进ALDH3A1去泛素化稳定,恢复线粒体相关内质网膜完整性及脂肪酸氧化,减轻脂质蓄积、氧化应激、上皮间质转化、炎症与胶原沉积,在体内改善肾功能与纤维化。
要点
- NGR2被鉴定为肾炎防衰方的核心活性成分,可直接结合CASP2。
- NGR2结合CASP2的CARD结构域且不遮蔽其UIML区,增加CASP2丰度与稳定性而非激活其凋亡蛋白酶活性。
- NGR2经CASP2/ALDH3A1轴恢复MAM完整性与脂肪酸氧化,减轻肾间质纤维化。
核心结论
- 肾炎防衰方与NGR2通过靶向CASP2/ALDH3A1轴恢复线粒体相关内质网膜功能与脂肪酸氧化,拮抗肾间质纤维化,为中药治疗慢性肾脏病提供分子依据。
研究设计与样本
- 在UUO大鼠与TGF-β1诱导的NRK-52E细胞中开展整合多组学分析,鉴定肾炎防衰方核心活性成分NGR2并验证其直接结合CASP2。
主要发现
- NGR2上调CASP2,增强CASP2–ALDH3A1相互作用并促进ALDH3A1去泛素化,从而稳定ALDH3A1。
- 该稳定作用恢复MAM完整性,并通过上调CPT1A、ACADL与PPARα改善脂肪酸氧化。
- NGR2减少脂质蓄积、氧化应激、上皮间质转化、炎症与胶原沉积;在体内改善肾功能与纤维化。
- NGR2结合CASP2的CARD结构域而不遮蔽其去泛素化功能所需的UIML区,增加CASP2丰度与稳定性而非激活其凋亡蛋白酶活性。
临床怎么用
- 原文未据此给出临床推荐,结论认为该机制为中药治疗慢性肾脏病提供了分子基础。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Proposed mechanism by which notoginsenoside R2 (NGR2) attenuates renal interstitial fibrosis. In injured renal tubular epithelial cells, CASP2 downregulation and enhanced ubiquitin-dependent degradation of ALDH3A1 disrupt mitochondria-associated endoplasmic reticulum membranes (MAMs) and impair fatty acid oxidation (FAO), leading to lipid accumulation and fibrosis. NGR2 binds to and stabilizes CASP2, enhances its interaction with ALDH3A1, and is proposed to promote ALDH3A1 deubiquitination and stabilization. These effects restore MAM integrity and FAO, reduce lipid accumulation, and alleviate renal interstitial fibrosis. ABSTRACT Renal interstitial fibrosis (RIF) is a major driver of chronic kidney disease (CKD) progression, yet effective therapies remain limited. The Shen-Yan-Fang-Shuai formula (SYFSF) exhibits clinical renoprotective effects; however, its active components and mechanisms remain unclear. This study identifies notoginsenoside R2 (NGR2) as a core active compound of SYFSF that directly binds to caspase-2 (CASP2). Integrative multi-omics analyses in unilateral ureteral obstruction (UUO) rats and transforming growth factor-β1 (TGF-β1)-induced NRK-52E cells demonstrate that NGR2 upregulates CASP2, enhances the CASP2–aldehyde dehydrogenase 3 family member A1 (ALDH3A1) interaction, and promotes ALDH3A1 deubiquitination, thereby stabilizing ALDH3A1. This stabilization restores the integrity of mitochondria-associated endoplasmic reticulum membranes (MAMs) and improves fatty acid oxidation (FAO) by upregulating carnitine palmitoyltransferase 1A (CPT1A), acyl-CoA dehydrogenase long chain (ACADL), and peroxisome proliferator-activated receptor α (PPARα). It also reduces lipid accumulation, oxidative stress, epithelial-mesenchymal transition (EMT), inflammation, and collagen deposition. In vivo, NGR2 ameliorates renal dysfunction and fibrosis. Mechanistically, NGR2 binds the caspase activation and recruitment domain (CARD) of CASP2 without occluding the ubiquitin-interacting motif-like (UIML) region required for its deubiquitinase function, thereby increasing CASP2 abundance and stability rather than activating its apoptotic protease activity, and facilitating ubiquitin chain removal from ALDH3A1. These findings demonstrate that SYFSF and NGR2 antagonize RIF by targeting the CASP2/ALDH3A1 axis to restore MAM function and FAO, providing a molecular basis for traditional Chinese medicine in CKD therapy.
引用
- Phytotherapy Research:Notoginsenoside R2 Antagonizes Renal Interstitial Fibrosis by Regulating Fatty Acid Oxidation via the CASP2/ALDH3A1 Axis
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。